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Abstract-In the setting of a questionable pulmonary nodule demonstrated by conventional radiographs, the 
place of CT in the diagnostic algorithm is not well established. We reviewed our experience in 50 consecutive 
patients referred to CT for a “possible pulmonary nodule.” From the chest radiographs we noted nodule 
location, maximum dimension, presence on one or both views, and presence on a previous radiograph (1 I 
year old), and nodules were categorized as “likely” or “unlikely” to be real parenchymal lesions based on 
radiographic appearance. Of a total of 56 questionable nodules, CT demonstrated no abnormality in 21 cases. 
parenchymal nodules in 16, scarring. atelectasis, or infiltrate in 1 I, and normal structural variants in 8. True 
pulmonary nodules were statistically significantly more frequently categorized as “likely” lesions than normal 
variants or no disease, but this was not of a magnitude to be clinically useful. Based on analysis of various 
radiographic features of equivocal nodules and their subsequent outcomes. we suggest a radiologic approach 
to the equivocal pulmonary nodule. 
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INTRODUCTION 
Computed tomography (CT) has assumed a major role in the evaluation of pulmonary parenchymal 
nodules in a variety of clinical settings. In patients with extrathoracic primary malignant neoplasms, 
CT is often used to detect pulmonary metastases, even when conventional chest radiographs are 
normal. In patients with a solitary pulmonary nodule demonstrated by conventional radiographs, CT 
densitometry may be the most effective way to determine the presence of calcification [I]. When a 
solitary nodule is felt to represent bronchogenic carcinoma, CT is considered by many to be an 
efficacious tool for noninvasive staging of disease extent [2]. 
In the clinical setting of a questionable nodule demonstrated by conventional radiographs, the place 
of CT in the diagnostic algorithm is not as well established. We reviewed our experience in 50 
consecutive patients referred to CT for a “possible pulmonary nodule.” The results of this review and 
our recommendations for this common clinical situation form the basis of this report. 
MATERIALS AND METHODS 
We retrieved the CT records at our hospital from 1 January 1982 to 15 August 1985 to identify 
all patients evaluated for the presence of one or more equivocal pulmonary nodules. We reviewed the 
corresponding posteroanterior (PA) and lateral chest radiographs without knowledge of the clinical 
history or the CT findings and noted the following parameters: nodule location, maximum dimension, 
presence on one or both views, and presence on a previous radiograph (greater than 1 year-old). 
Nodules were also categorized as “likely” or “unlikely” to be real parenchymal lesions based on their 
radiographic appearance. We then reviewed the CT scans to look for findings to explain the lesions 
in question. CT scan findings were categorized as follows: “nodule,” “ clear-cut scarring, atelectasis, 
or infiltrate,” “ normal structural variant,” or “no disease noted.” If a nodule was present, we looked 
for calcification or for other nodules. All CT scans were performed on GE 8800 or 9800 CT scanners 
with scan times of 4.8-5.6 sec. Contiguous 1 cm thick slices were obtained from the lung apices 
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through the lung bases and were photographed at lung (level = -600 H.U., width = 1000 H.U.) and 
soft tissue (level = 30 H.U., width = 500 H.U.) windows; repeat contiguous 5 mm thick slices were 
sometimes obtained in areas of suspected abnormality. 
Careful chart review was then performed addressing the following points: clinical history pertaining 
to the chest radiograph, subsequent workup, and current patient and lesion status. Clinical indications 
for chest radiography varied from routine evaluation to symptomatic for possible lung neoplasm 
(hemoptysis, new onset of cough, weight loss) to known malignancy. Subsequent workup after chest 
CT included biopsy in four patients. In those patients without pathologic proof of lesion etiology, 
we attempted careful clinical correlation, including follow-up chest radiography and/or CT, to 
determine the nature of the pulmonary nodule. For example, nodules responding to antineoplastic 
therapy synchronously with known malignancy at other sites were considered probably malignant, 
while nodules that resolved with antibiotic therapy in patients with clinical evidence of infection (fever, 
leukocytosis) were considered probably inflammatory. Nodules were considered benign if stability or 
regression was demonstrated for at least 1 year in the absence of antineoplastic therapy. 
The statistical workup of these data used paired x’ analysis. 
RESULTS 
Fifty patients with a total of 56 questionable pulmonary nodules at conventional chest radiography 
underwent CT scanning. Pathologic or clinical confirmation was available in 71%. Overall, 16 of 56 
equivocal nodules were shown to be real at CT. Eleven equivocal nodules were explained by scar, 
atelectasis, or infiltrate (SAI), while 8 represented normal structural variants. CT demonstrated no 
abnormality for 21 of 56 suspected nodules. Subsequent follow-up of the latter 21 patients revealed 
no parenchymal neoplasms that were missed by CT. Mean nodule size was similar whether CT showed 
no disease, a true nodule, SAI, or a normal structural variant (see Table 1). Overall, 61% of the 
equivocal nodules in this study were 1 cm or less in size. 
There was no statistical difference in mean patient age or percentage of lesions present on old 
radiographs for any CT outcome. Similarly, there was considerable overlap in clinical history for all 
outcomes. True pulmonary nodules were more likely to be seen on two views than no disease (44 vs 
15%) but statistical significance was not achieved (P = 0.12). 
The assessment of likelihood of a real lesion demonstrated statistically significant differences among 
the various outcomes. True pulmonary nodules, 8 I % of which were categorized as likely lesions, were 
more often considered real lesions when compared to normal variants (P = 0.0009) or no disease 
(P = 0.01). 
In assessing location of the equivocal nodules, we emphasized the relative position of the lesions 
with respect to ribs and vertebrae. Many equivocal nodules projected over a bony structure (36/56 
overall, including 7 of 16 true nodules), but only 1 of 12 lesions that projected over two ribs turned 
out to be a true nodule (Fig. 1). Furthermore, all four equivocal nodules that projected over the first 
or second costochondral junction were due to prominence of these junctions (Fig. 2). 
Of 16 true nodules, seven were considered benign, including three that were granulomas, one that 
represented chronic inflammation, one that resolved with antibiotic therapy, one that was diffusely 
calcified at CT densitometry, and one that was densely calcified and showed no growth over a 2-year 
period. Of the remaining nodules, four demonstrated interval growth, two were biopsy-proven 
bronchogenic carcinomas, two were lost to follow-up in patients who died of underlying malignancy, 
and one responded to antineoplastic therapy. CT revealed multiple nodules in two patients who each 
had only one lesion seen on conventional chest radiographs. 
Of patients with multiple equivocal nodules, one had 1 benign nodule and 2 “no disease noted” 
in the areas of interest, one had 2 “no disease noted,” one had 1 “probably malignant” and 1 “no 
disease noted,” one had 2 biopsy-proven benign nodules, and one had 2 biopsy-proven malignant 
nodules. Interestingly, seven patients were thought by their referring clinicians to have equivocal 
pulmonary nodules despite a formal radiologic interpretation of “no pulmonary nodules.” CT 
demonstrated 3 SAI, 2 costochondral junction calcifications, 1 no disease, and 1 true nodule (Fig. 
3) in this group of patients. The patient with a true nodule had adenocarcinoma of unknown primary 
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Fig. 1. Equivocal nodule projected over left third anterior and seventh posterior ribs (arrowhead). CT revealed 
no abnormality. 
DISCUSSION 
The effective management of patients with equivocal pulmonary nodules requires differentiation of 
true intraparenchymal nodules, normal structural variants, technical artifacts, non-nodular pul- 
monary abnormalities, and extrapulmonary lesions. While it is of interest that a chest radiologist could 
characterize equivocal nodules as likely or unlikely to be real lesions with some accuracy, this was 
clearly not of a magnitude sufficient to serve in the clinical setting. Follow-up conventional chest 
radiography is another method for establishing the significance of an equivocal nodule, but the 
diagnostic delay that this entails will not always be clinically acceptable. Other modalities for further 
evaluation of equivocal nodules have included chest fluoroscopy, oblique chest radiographs, and/or 
conventional chest tomography. With the advent of CT there has been confusion on the part of 
clinicians and radiologists as to which studies should be obtained for a questionable nodule. 
In our institution the availability of CT has resulted in a marked reduction in the number of 
conventional tomograms performed, and chest fuoroscopy is virtually never done. The reduced role 
of conventional tomography is probably well deserved. CT and conventional tomography are roughly 
similar in terms of cost (approximately $500 vs $300 in our institution) and radiation dose, and CT 
has proven to be more sensitive at detecting parenchymal lesions [3-51 and far better at evaluating 
extraparenchymal abnormalities of the mediastinum, hila, chest wall, and upper abdomen [6]. 
Oblique chest radiographs are, from the standpoint of the radiologist, perhaps more convenient to 
order than chest fluoroscopy. However, this convenience is negated in our experience by the frequent 
nondiagnostic nature of the resultant study. At chest fluoroscopy, it is easier to define the angle of 
obliquity and degree of inspiration at which an equivocal nodule is viewed to maximum diagnostic 
advantage. 
Chest fluoroscopy has several attractive features in comparison with CT and conventional 
tomography. It is far less expensive (less than $100 in our institution), much faster, more convenient 
to schedule and perform, and lower in patient radiation dose. The fact that fluoroscopy can often 
be performed immediately after an equivocal nodule is detected on chest radiographs means that the 
patient will sometimes be spared the anxiety of waiting for a CT scan to rule out cancer. The major 











Fig. 2. Equivocal nodule secondary to prominent costochondral junction. (A) PA chest radiograph shows 
questionable nodule at left first costochondral junction (arrowhead). (B) CT image demonstrates prominent 
calcified costochondral cartilage (arrowhead). 
aback of chest fluoroscopy is that it is not nearly as definitive as CT. This is becoming even 
problem because radiology residency programs do not encourage the development of 
:oscopic skills as much as they did in the past. 
more 
chest 
‘e feel that the approach to the equivocal pulmonary nodule should rely on the relative adval ntages 
rest fluoroscopy and CT. Chest fluoroscopy can be a fast and inexpensive screening tool for 1 esions 
are not likely to be real nodules. From this study, that would apply to equivocal nc odules 
ecting over two ribs or over the first or second costochondral junction. For all other equ ivocal 
ules (and for patients in whom screening chest fluoroscopy demonstrates an underlying part :nchy- 
abnormality), we recommend CT to distinguish true nodules from scars, airspace disease, n .ormal 










Equivocal nodule referred to CT despite radiologic misdiagnosis. (A) PA chest radiograph, offic 
,eted as normal, demonstrates a small nodule over the right posterior eighth rib (arrowhead). (B 
confirms a parenchymal nodule (arrowhead). 
aially 
8) CT 
ants, or no disease. In patients with true nodules, CT densitometry can be performed, in 
s establishing the presence of diffuse calcification of a nodule. 
T evaluation of equivocal pulmonary nodules is not without problems. The CT demonst 
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to have multiple clinically-unsuspected nodules. From our previous CT study of multiple pulmonary 
nodules, we feel that clinical correlation is very important in patients with one or more noncalcified 
pulmonary nodules [7]. Closer interval follow-up CT and nodule biopsy are diagnostic alternatives 
whose appropriateness in a given patient is best decided by the referring physician. 
SUMMARY 
In the setting of an equivocal pulmonary nodule demonstrated by conventional chest radiographs, 
CT accurately distinguishes among real nodules, scars, atelectasis or infiltrate, normal structural 
variants, and no disease. Chest fluoroscopy, because it is fast and inexpensive, is an attractive 
alternative diagnostic tool for nodules that are unlikely to be real. From our experience this would 
apply to equivocal nodules projecting over two ribs or over the first or second costochondral junction. 
For all other equivocal nodules, we suggest CT. 
REFERENCES 
1. S. S. Siegelman, E. A. Zcrhouni, F. P. Leo, N. F. Khouri and F. P. Stitik, CT of the solitary pulmonary nodule, Am. 
J. Roenrg. 135, l-13 (1980). 
2. G. M. Glazer, M. B. Orringer, B. H. Gross and L. E. Quint, The mediastinum in non-small cell lung cancer: CT-surgical 
correlation, Am. J. Roentg. 142, 1101-1105 (1984). 
3. E. G. Schaner. A. E. Chang, J. L. Doppman, D. M. Conkle, M. W. Flye and S. A. Rosenberg, Comparison of computed 
and conventional whole lung tomography in detecting pulmonary nodules: a prospective radiologic-pathologic study, Am. 
J. Roentg. 131, 51-54 (1978). 
4. J. R. Muhm, L. R. Brown, J. K. Crowe, p. F. Sheedy II, R. R. Hattery and D. H. Stephens, Comparison of whole lung 
tomography and computed tomography for detecting pulmonary nodules, Am. J. Roenfg. 131, 981-984 (1978). 
5. R. A. Mintzer, S. R. Malave, H. L. Nieman, L. L. Michaelis, R. M. Vanecko and J. H. Sanders, Computed vs conventional 
tomography in evaluation of primary and secondary pulmonary neoplasms, Radiology 132, 653-659 (1979). 
6. P. J. Sones Jr, W. E. Torres, R. S. Colvin, W. L. Meier, P. Sprawls and J. V. Rogers Jr, Effectiveness of CT in evaluating 
intrathoracic masses, Am. J. Roentg. 139, 469475 (1982). 
7. B. H. Gross, G. M. Glazer and F. L. Bookstein, Multiple pulmonary nodules detected by computed tomography: diagnostic 
implications, J. Cornput. assist. Tomogr. 9, 880-885 (1985). 
About the Author-MURRAY A. HOWE received his M.D. from the University of Michigan, where he is 
currently continuing his training in the radiology residency program. 
About the Author-BARRY H. GROSS received his M.D. from the University of Michigan. Following radiology 
residency at the University of Cincinnati, he was a fellow in body computed tomography and ultrasonography 
at the University of California, San Francisco. He is currentlv Associate Professor of Radiolonv. Director. 
Division of Chest Radiology, and Associate Director, Division of Body Computed Tomography at the 
University of Michigan. 
